FY2025 EPS Estimates for SPRY Cut by Cantor Fitzgerald
MarketBeat
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for ARS Pharmaceuticals in a research note issued on Thursday, May 15th. Cantor Fitzgerald analyst J. Schimmer now expects that the compa
NASDAQ:SPRY